SCHEMBL7779407

SCHEMBL7779407

CCCc1cccc(CC#N)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
ENPP2 Q13822 1/20 0.50
MMP3 P08254 1/20 0.47
CTSS P25774 2/20 0.45
CTSK P43235 2/20 0.45
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
DRD2 P14416 2/20 0.43
DRD3 P35462 2/20 0.43
FFAR1 O14842 1/20 0.41
DRD1 P21728 1/20 0.40
DRD4 P21917 1/20 0.40
DRD5 P21918 1/20 0.40
CYP1A1 P04798 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP1B1 Q16678 1/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20940016 0.89 MEN1 (0.52) MEN1KMT2AENPP2MMP3KDM4E
SCHEMBL23588049 0.87 LPL (0.51) MEN1KMT2AENPP2MMP3TDP1
SCHEMBL237972 0.85 ENPP2 (0.63) MEN1KMT2AENPP2MMP3KDM4E
SCHEMBL7196848 0.83 ENPP2 (0.53) MEN1KMT2AENPP2MMP3CTSS
Benzene SCHEMBL5438521 0.83 ENPP2 (0.61) MEN1KMT2AENPP2MMP3KDM4E
SCHEMBL380954 0.82 CNR1 (0.50) MEN1KMT2ACTSSCTSKDRD2
SCHEMBL910727 0.80 MEN1 (0.41) MEN1KMT2ACTSSCTSKDRD2
SCHEMBL27385716 0.80 MEN1 (0.55) MEN1KMT2AENPP2MMP3KDM4E
SCHEMBL31258 0.79 LPL (0.45) MEN1KMT2AKDM4ETDP1CNR1
SCHEMBL27287428 0.77 MEN1 (0.52) MEN1KMT2AENPP2MMP3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617762-B2 Carboxy derivatives with antiinflamatory properties SITRYX THERAPEUTICS LIMITED (GB) 2026-05-05 US disclosed
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES SITRYX THERAPEUTICS LIMITED (GB) 2023-07-13 US disclosed
CN-115066418-A Carboxy derivatives with anti-inflammatory properties 西特瑞治疗有限公司 2022-09-16 CN disclosed
EP-0949247-B1 Process for the preparation of piperidinylidene derivatives TAKASAGO PERFUMERY CO LTD (JP) 2001-09-12 EP disclosed
US-6008358-A Process for the preparation of piperidinylidene derivative TAKASAGO INTERNATIONAL CORPORATION (JP) 1999-12-28 US disclosed
EP-0949247-A1 Process for the preparation of piperidinylidene derivatives Takasago International Corporation (JP) 1999-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES CPA2, RO60, C5AR1 MEN1 4504/4885KMT2A 3125/4885ENPP2 132/4885
US-12617762-B2 Carboxy derivatives with antiinflamatory properties CCR1, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 MEN1 4588/4885KMT2A 4179/4885ENPP2 1409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.